Mira Pharmaceuticals (MIRA) P/B (2023 - 2026)
Mira Pharmaceuticals (MIRA) P/B from Aug 3, 2023 to Jun 3, 2026. The TTM Mira Pharmaceuticals (MIRA) P/B is 4.54. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Mira Pharmaceuticals (MIRA)
| Year | P/B | Change |
|---|---|---|
| 2026 | 4.54 | -25.52% |
| 2025 | 6.10 | -28.98% |
| 2024 | 8.58 | +348.98% |
| 2023 | 1.91 | N/A |
Comparison Mira Pharmaceuticals (MIRA) P/B with competitors
Mira Pharmaceuticals (MIRA) P/B is 4.54.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.67 | -85.31% |
| GRFS | Grifols SA | 0.86 | -81.01% |
| SNY | Sanofi | 1.25 | -72.42% |
| BIIB | Biogen Inc | 1.55 | -65.77% |
| PFE | Pfizer Inc | 1.66 | -63.47% |
| OGN | Organon & Company | 3.88 | -14.48% |
| GSK | GSK Plc | 4.30 | -5.36% |
| BMY | Bristol-Myers Squibb Company | 5.91 | +30.20% |
| AZN | Astrazeneca plc | 6.07 | +33.72% |
| NVO | Novo Nordisk | 6.24 | +37.47% |
| MRK | Merck & Co Inc | 6.47 | +42.53% |
| JNJ | Johnson & Johnson | 6.86 | +51.13% |
| GILD | Gilead Sciences Inc | 7.06 | +55.53% |
| NVS | Novartis AG | 7.49 | +65.00% |
| MDCX | MDCorp | 13.18 | +190.35% |
| NSRX | Nasus Pharma Ltd | 14.22 | +213.27% |
| AMGN | AMGEN Inc | 19.74 | +334.87% |
| SCLX | Scilex Holding Company | 28.85 | +535.56% |
| LLY | Lilly(Eli) & Company | 30.95 | +581.83% |
| ABBV | Abbvie Inc | 50.46 | +1011.63% |